Skip to main content
Top
Literature
1.
go back to reference Australasian Society for HIV Medicine. B Positive—all you wanted to know about hepatitis B: a guide for primary care providers. Sydney: ASHM and The Cancer Council NSW; 2008. Australasian Society for HIV Medicine. B Positive—all you wanted to know about hepatitis B: a guide for primary care providers. Sydney: ASHM and The Cancer Council NSW; 2008.
2.
go back to reference Digestive Health Foundation. Chronic hepatitis B (CHB) recommendations. 2nd ed. Victoria: Gastroenterological Society of Australia; 2009. Digestive Health Foundation. Chronic hepatitis B (CHB) recommendations. 2nd ed. Victoria: Gastroenterological Society of Australia; 2009.
4.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef
5.
go back to reference Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ides analogues treatment for chronic hepatitis B. J Hepatol. 2011;54:12–8.PubMedCrossRef Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ides analogues treatment for chronic hepatitis B. J Hepatol. 2011;54:12–8.PubMedCrossRef
6.
go back to reference Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol. 2012;4:43–9.PubMedCentralPubMedCrossRef Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol. 2012;4:43–9.PubMedCentralPubMedCrossRef
7.
go back to reference Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis. 2001;33:865–72.PubMedCrossRef Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis. 2001;33:865–72.PubMedCrossRef
8.
go back to reference Cheney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30 Suppl 2:S171–6.CrossRef Cheney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30 Suppl 2:S171–6.CrossRef
Metadata
Title
Adherence to oral antivirals in patients with chronic hepatitis B infection
Authors
Mayank Jain
Sagar Adkar
Chandrashekhar Waghmare
Publication date
01-07-2014
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2014
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-013-0433-z

Other articles of this Issue 4/2014

Indian Journal of Gastroenterology 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.